COVID-19 and Inflammatory Bowel Disease

por Summa, Keith C., Hanauer, Stephen B.
Publicado 2023

Checkpoint Inhibitor–Induced Colitis: A New Type of Inflammatory Bowel Disease?

por Bertha, Madeline, Bellaguara, Emanuelle, Kuzel, Timothy, Hanauer, Stephen
Publicado 2017

Prevalence and screening for anaemia in mild to moderate Crohn's disease and ulcerative colitis in the United States, 2010–2014

por Akhuemonkhan, Eboselume, Parian, Alyssa, Miller, Kay, Hanauer, Stephen, Hutfless, Susan
Publicado 2017

Two Brothers with Skewed Thiopurine Metabolism in Ulcerative Colitis Treated Successfully with Allopurinol and Mercaptopurine Dose Reduction

por Hoentjen, Frank, Hanauer, Stephen B., de Boer, Nanne K., Rubin, David T.
Publicado 2011

Persistent perineal sinus following proctocolectomy in the inflammatory bowel disease patient

por Papasotiriou, Sam D., Dumanian, Gregory A., Strong, Scott A., Hanauer, Stephen B.
Publicado 2023

Primary Adenocarcinoma of an Ileostomy in Crohn's Disease

por Liu, Kevin, Prasad, Meena A., Lo, Amy, Bellaguarda, Emanuelle, Strong, Scott, Hanauer, Stephen B.
Publicado 2016

Interferon beta-1a for the maintenance of remission in patients with Crohn's disease: results of a phase II dose-finding study

por Pena Rossi, Claudia, Hanauer, Stephen B, Tomasevic, Ratko, Hunter, John O, Shafran, Ira, Graffner, Hans
Publicado 2009

Use of the Endoscopic Healing Index for Monitoring of Disease Activity in Patients With Crohn’s Disease in the COVID Era

por Abreu, Maria T, Okada, Lauren, Dervieux, Thierry, Luo, Allison, Jain, Anjali, Ritter, Timothy, Hanauer, Stephen B
Publicado 2020

Pancreatitis associated with azathioprine and 6-mercaptopurine use in Crohn’s disease: a systematic review

por Gordon, Morris, Grafton-Clarke, Ciaran, Akobeng, Anthony, Macdonald, John, Chande, Nilesh, Hanauer, Stephen, Arnott, Ian
Publicado 2020

Standard Colonic Lavage Alters the Natural State of Mucosal-Associated Microbiota in the Human Colon

por Harrell, Laura, Wang, Yunwei, Antonopoulos, Dionysios, Young, Vincent, Lichtenstein, Lev, Huang, Yong, Hanauer, Stephen, Chang, Eugene
Publicado 2012

Postinduction serum infliximab trough level and decrease of C-reactive protein level are associated with durable sustained response to infliximab: a retrospective analysis of the A...

por Cornillie, Freddy, Hanauer, Stephen B, Diamond, Robert H, Wang, Jianping, Tang, Kezhen L, Xu, Zhenhua, Rutgeerts, Paul, Vermeire, Séverine
Publicado 2014

Rapid Changes in Laboratory Parameters and Early Response to Adalimumab: A Pooled Analysis From Patients With Ulcerative Colitis in Two Clinical Trials

por Hanauer, Stephen, Sandborn, William J, Colombel, Jean-Frederic, Vermeire, Severine, Petersson, Joel, Kligys, Kristina, Zhou, Qian, Lazar, Andreas, Reinisch, Walter
Publicado 2019

Atovaquone attenuates experimental colitis by reducing neutrophil infiltration of colonic mucosa

por Manzanares, Laura D., David, Joseph, Ren, Xingsheng, Yalom, Lenore K., Piccolo, Enzo B., Dehghan, Yalda, David, Aidan J., Hanauer, Stephen B., Sumagin, Ronen
Publicado 2022

Safety, Pharmacokinetics, and Efficacy of Olorinab, a Peripherally Acting, Highly Selective, Full Agonist of the Cannabinoid Receptor 2, in a Phase 2a Study of Patients With Chroni...

por Yacyshyn, Bruce R, Hanauer, Stephen, Klassen, Preston, English, Brett A, Stauber, Kathe, Barish, Charles F, Gilder, Kye, Turner, Stewart, Higgins, Peter D R
Publicado 2020

A randomized trial of the effects of the no-carrageenan diet on ulcerative colitis disease activity

por Bhattacharyya, Sumit, Shumard, Theresa, Xie, Hui, Dodda, Amar, Varady, Krista A., Feferman, Leo, Halline, Allan G., Goldstein, Jay L., Hanauer, Stephen B., Tobacman, Joanne K.
Publicado 2017

Switching Between Adalimumab Reference Product and BI 695501 in Patients with Chronic Plaque Psoriasis (VOLTAIRE-X): A Randomized Controlled Trial

por Menter, Alan, Cohen, Stanley, Kay, Jonathan, Strand, Vibeke, Gottlieb, Alice, Hanauer, Stephen, Eduru, Sravan Kumar, Buschke, Susanne, Lang, Benjamin, Liesenfeld, Karl-Heinz, Schaible, Jennifer, McCabe, Dorothy
Publicado 2022

Briakinumab for Treatment of Crohn's Disease: Results of a Randomized Trial

por Panaccione, Remo, Sandborn, William J., Gordon, Glenn L., Lee, Scott D., Safdi, Alan, Sedghi, Shahriar, Feagan, Brian G., Hanauer, Stephen, Reinisch, Walter, Valentine, John F., Huang, Bidan, Carcereri, Roberto
Publicado 2015

Noninvasive Targeted Crohn Disease Management by Combining Endoscopic Healing Index and Therapeutic Drug Monitoring

por Hemperly, Amy, Dubinsky, Marla C, Yarur, Andres, Afzali, Anita, Hanauer, Stephen, Kugathasan, Subra, Long, Millie D, Rabizadeh, Shervin, Sockolow, Robbyn, Okada, Lauren, Jain, Anjali, Abreu, Maria T, Vande Casteele, Niels
Publicado 2021

Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study

por Sandborn, William J, Feagan, Brian G, Hanauer, Stephen, Vermeire, Severine, Ghosh, Subrata, Liu, Wenzhong J, Petersen, AnnKatrin, Charles, Lorna, Huang, Vivian, Usiskin, Keith, Wolf, Douglas C, D’Haens, Geert
Publicado 2021

Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study

por Zou, Fangwen, Faleck, David, Thomas, Anusha, Harris, Jessica, Satish, Deepika, Wang, Xuemei, Charabaty, Aline, Ernstoff, Marc S, Glitza Oliva, Isabella C, Hanauer, Stephen, McQuade, Jennifer, Obeid, Michel, Shah, Amishi, Richards, David M, Sharon, Elad, Wolchok, Jedd, Thompson, John, Wang, Yinghong
Publicado 2021